New Frontiers in Aerosol Delivery During Mechanical Ventilation

Author: Dhand, Rajiv

Source: Respiratory Care, Volume 49, Number 6, June 2004 , pp. 666-677(12)

Publisher: The Journal Respiratory Care Company

Buy & download fulltext article:

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Abstract:

The scientific basis for inhalation therapy in mechanically-ventilated patients is now firmly established. A variety of new devices that deliver drugs to the lung with high efficiency could be employed for drug delivery during mechanical ventilation. Encapsulation of drugs within liposomes could increase the amount of drug delivered, prolong the effect of a dose, and minimize adverse effects. With improved inhalation devices and surfactant formulations, inhaled surfactant could be employed for several indications in mechanically-ventilated patients. Research is unraveling the causes of some disorders that have been poorly understood, and our improved understanding of the causal mechanisms of various respiratory disorders will provide new applications for inhaled therapies.

Keywords: AEROSOL; MECHANICAL VENTILATION; VENTILATOR; LIPOSOMES; SURFACTANT; PULMONARY ALVEOLAR PROTEINOSIS

Document Type: Research article

Affiliations: 1: Division of Pulmonary, Critical Care, and Environmental Medicine, Department of Internal Medicine, MA-421 Health Sciences Center, DC043.00, 1 Hospital Drive, University of Missouri-Columbia, Columbia MO 65212;, Email: dhandr@health.missouri.edu

Publication date: 2004-06-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page